Influence of substance use on male reproductive health and offspring outcomes

• Published in: Nature reviews. Urology Vol. 21; no. 9; p. 534
• Main Authors: Lo, Jamie O, Hedges, Jason C, Chou, Wesley H, Tager, Kylie R, Bachli, Ian D, Hagen, Olivia L, Murphy, Susan K, Hanna, Carol B, Easley, 4th, Charles A
• Format: Journal Article
• Language: English
• Published: England 01.09.2024
• Subjects: COVID-19 - epidemiology; Female; Humans; Infertility, Male - epidemiology; Infertility, Male - etiology; Male; Pregnancy; Prenatal Exposure Delayed Effects; Reproductive Health; Substance-Related Disorders - epidemiology
• ISSN: 1759-4820
• DOI: 10.1038/s41585-024-00868-w

The prevalence of substance use globally is rising and is highest among men of reproductive age. In Africa, and South and Central America, cannabis use disorder is most prevalent and in Eastern and South-Eastern Europe, Central America, Canada and the USA, opioid use disorder predominates. Substance use might be contributing to the ongoing global decline in male fertility, and emerging evidence has linked paternal substance use with short-term and long-term adverse effects on offspring development and outcomes. This trend is concerning given that substance use is increasing, including during the COVID-19 pandemic. Preclinical studies have shown that male preconception substance use can influence offspring brain development and neurobehaviour through epigenetic mechanisms. Additionally, human studies investigating paternal health behaviours during the prenatal period suggest that paternal tobacco, opioid, cannabis and alcohol use is associated with reduced offspring mental health, in particular hyperactivity and attention-deficit hyperactivity disorder. The potential effects of paternal substance use are areas in which to focus public health efforts and health-care provider counselling of couples or individuals interested in conceiving.